For Safety. Jazz may terminate effective immediately upon written notice to Codiak in the event of: (a) withdrawal or suspension of any Regulatory Approval for a Licensed Product in the United States, Japan or a Major European Country; (b) a Regulatory Authority notifies Jazz or its Affiliate that there is a safety issue regarding any Licensed Compound or Licensed Product; or. (c) Jazz in good faith determines that it is not advisable to continue to Develop or Commercialize any Licensed Compound or Licensed Product as a result of a safety concern regarding the use thereof for the Indication to which such Licensed Compound or Licensed Product is directed, based on specific results generated in connection with the Development conducted hereunder by either Party, safety reports, evidence provided in scientific publications or other objective evidence from credible sources.
Appears in 3 contracts
Sources: Collaboration and License Agreement (Codiak BioSciences, Inc.), Collaboration and License Agreement (Codiak BioSciences, Inc.), Collaboration and License Agreement (Codiak BioSciences, Inc.)